Literature DB >> 7034764

Intravascular coagulation in mice by the compact-colony-forming active substance (CCFAS) extracted from a strain of Staphylococcus aureus.

K Yoshida, T Ohtomo, Y Ichiman, S Narikawa, K Oikawa.   

Abstract

The compact-colony-forming active substance (CCFAS) extracted from a Staphylococcus aureus strain was capable of killing mice only when Staph. aureus, Staph. epidermidis or Escherichia coli was injected i.v. before the injection of CCFAS. In the mice killed 30 min after treatment with heat-killed Staph. aureus and CCFAS, remarkable congestion of the lung and thrombus-like lesions in the kidney were observed. In the mice killed 6 h after injection with CCFAS and living Staph. aureus congestion and inflammatory-cell filtration were found in the liver, especially within the Glisson's capsule. However, when mice were killed 30 days after treatment with CCFAS and Staph. aureus, fibrin and hyalin thrombi were observed most frequently in the renal glomeruli but also in the liver and lung.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7034764      PMCID: PMC2041728     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  17 in total

1.  Extraction of a compact colony-forming active substance from Staphylococcus aureus strains.

Authors:  K Yoshida; T Otomo; Y Minegishi
Journal:  Jpn J Microbiol       Date:  1975-02

2.  Interaction of an alkali stable polysaccharide from cell surface of Staphylococci with human fibrinogen.

Authors:  K Yoshida; T Ohtomo; Y Usui
Journal:  Experientia       Date:  1978-07-15

3.  Interactions between dextran, fibrinogen and plasma membranes.

Authors:  M W Rampling
Journal:  Biochem Pharmacol       Date:  1976-04-01       Impact factor: 5.858

4.  Possible pathogenetic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC).

Authors:  M W Rytel; T H Dee; J E Ferstenfeld; G T Hensley
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

5.  Comparison of three blood-clotting substances in Staphylococcus aureus strains.

Authors:  K Yoshida; M Takahashi; K Haga; E Kono; H Kushiro; S Ito
Journal:  J Clin Microbiol       Date:  1980-03       Impact factor: 5.948

6.  Staphylococcal clumping and fibrinogen and fibrin degradation products in inflammatory exudate.

Authors:  J Hawiger; A Hawiger; M G Koenig
Journal:  Proc Soc Exp Biol Med       Date:  1971-01

7.  Staphylococci-induced human platelet injury mediated by protein A and immunoglobulin G Fc fragment receptor.

Authors:  J Hawiger; S Steckley; D Hammond; C Cheng; S Timmons; A D Glick; R M Des Prez
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

8.  Mechanism of compact-colony formation by strains of Staphylococcus aureus in serum soft agar.

Authors:  K Yoshida; T Ohtomo; Y Minegishi
Journal:  J Gen Microbiol       Date:  1977-01

9.  Mediation systems in bacterial lipopolysaccharide-induced hypotension and disseminated intravascular coagulation. I. The role of complement.

Authors:  R J Ulevitch; C G Cochrane; P M Henson; D C Morrison; W F Doe
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

10.  Staphylocoagulase as a hemostatic agent.

Authors:  B Mojovic; N Mojovic; M Tager; M C Drummond
Journal:  Yale J Biol Med       Date:  1969-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.